Viibryd for Anxiety: What the Trials Show

Viibryd is a depression medication on paper, yet three large trials tested it for anxiety, and what they found is more nuanced than either a yes or a no. If you’re on Viibryd for depression and wondering whether it’s helping your anxiety too, or a prescriber has mentioned it after other medications didn’t suit you, the trial details matter.

Anxiety and mood both depend partly on serotonin, a chemical messenger your brain uses to regulate how strongly you react to stress. According to the FDA prescribing information, vilazodone, the active ingredient in Viibryd, blocks serotonin reuptake like an SSRI and also acts as a partial agonist at 5-HT1A receptors, a specific serotonin receptor. That dual action targets the serotonin system with real precision, though the label notes the role of the 5-HT1A effect is still unknown.

The established approach to generalized anxiety disorder, or GAD, starts with well-studied medications. A 2019 Lancet meta-analysis of 89 trials and 25,441 patients found that duloxetine, pregabalin, venlafaxine, and escitalopram worked better than placebo with relatively good acceptability. The results are real, and the science is well established.

But first-line options don’t work for or suit everyone, and at Siggy we’d rather walk you through what the evidence actually shows for a less familiar option than pretend there’s only one path.

For Viibryd, that evidence comes from three phase 3 trials in GAD. A pooled GAD trial analysis covering 1,462 patients found that 48% responded to vilazodone compared with 39% on placebo, and 27% versus 21% reached remission. Viibryd remains off-label for anxiety, and any decision to use it should rest on that clinical evidence.

What This Page Covers

• Is Viibryd FDA-Approved for Anxiety?
• What Did the Anxiety Trials Show?
• How Big Is the Benefit?
• Does Viibryd Help Social Anxiety?
• What Side Effects Showed Up in the Anxiety Trials?
• Why Does Viibryd Have to Be Taken With Food?
• Who Might Consider Viibryd for Anxiety?
• How Siggy Fits In
• Start Your Anonymous Intake

Is Viibryd FDA-Approved for Anxiety?

Viibryd isn’t FDA-approved for anxiety. The label approves it for one use: major depressive disorder in adults. Using it for anxiety is off-label, which means a prescriber chooses it based on research and clinical judgment rather than an FDA-approved indication.

Off-label prescribing is common and legal, and it isn’t a red flag on its own. It does mean Viibryd’s anxiety use hasn’t been FDA-approved, so it’s worth understanding exactly what those studies found.

What Did the Anxiety Trials Show?

All three trials were 8-week, randomized, double-blind, placebo-controlled studies in adults with GAD, and each used the Hamilton Anxiety Rating Scale, a clinician-rated anxiety measure, as the main outcome. Here’s how they compare.

Trial	Dose	Patients	Anxiety Result
Fixed-dose trial	20 mg or 40 mg	680	40 mg beat placebo, 20 mg didn’t
Flexible-dose trial 1	20 to 40 mg	395	Beat placebo
Flexible-dose trial 2	20 to 40 mg	400	Beat placebo
Pooled analysis	20 to 40 mg	1,462	48% vs 39% response

In the 2015 fixed-dose trial, vilazodone 40 mg improved anxiety scores more than placebo, but 20 mg didn’t reach statistical significance. In the first 2015 flexible-dose trial, vilazodone at 20 to 40 mg beat placebo on anxiety, though not on a measure of daily functioning. In the second 2016 flexible-dose trial, vilazodone beat placebo on both anxiety and functional impairment.

All three trials were conducted by researchers at the manufacturer’s research institute, which is typical for drug development studies and worth keeping in mind.

How Big Is the Benefit?

The benefit was real but modest. In the pooled analysis, vilazodone lowered anxiety scores by about 1.8 points more than placebo on a 56-point scale. Both psychic anxiety, like worry and tension, and somatic anxiety, like muscle and heart symptoms, improved more on vilazodone.

Put another way, about 9 more people out of every 100 responded on vilazodone than on placebo. That’s a meaningful difference for some people and a small one for others. Many people in the placebo groups also improved, which is common in anxiety trials.

For context, the Lancet meta-analysis found several other medications more effective than placebo with good acceptability, and those options are typically tried first. Our guide to generalized anxiety disorder covers first-line treatment in more detail.

Does Viibryd Help Social Anxiety?

The evidence is very limited. In a small social anxiety trial of 44 adults over 12 weeks, vilazodone improved social anxiety scores more than placebo. The authors called it promising but stressed that larger studies are needed. There isn’t enough evidence to recommend Viibryd for social anxiety, panic disorder, or other anxiety conditions.

What Side Effects Showed Up in the Anxiety Trials?

Side effects were more common on vilazodone than on placebo. In the fixed-dose trial, about 71% of people on vilazodone reported a side effect compared with 62% on placebo. Nausea, diarrhea, dizziness, vomiting, and fatigue were at least twice as common on vilazodone.

In the second flexible-dose trial, 71% of people on vilazodone completed the study compared with 81% on placebo. Side effects at least twice as common on vilazodone included nausea, diarrhea, dizziness, fatigue, delayed ejaculation, and erectile dysfunction.

Stomach side effects are the best known. In the label’s depression trials, diarrhea affected 26% to 29% of people on Viibryd versus 10% on placebo, and nausea affected 22% to 24% versus 7%. Our guide to Viibryd side effects covers what helps.

Sexual side effects are more complicated. A pooled sexual function analysis of the three anxiety trials found that sexual function scores changed similarly on vilazodone and placebo, though erectile dysfunction and delayed ejaculation occurred in about 2% of men on vilazodone. The label still warns that SSRIs, including Viibryd, can cause sexual side effects.

On safety, a pooled suicidality analysis of the anxiety trials found suicide-related adverse events in less than 1% of people on vilazodone or placebo. Like other antidepressants, Viibryd carries a boxed warning about suicidal thoughts in children, teens, and young adults, and anyone starting it should be monitored. If you’re having thoughts of suicide, call or text 988, or call 911 if you’re in immediate danger.

Why Does Viibryd Have to Be Taken With Food?

The label states that taking vilazodone on an empty stomach can cut total blood levels by about half, which may make it less effective. That’s why the label calls for taking every dose with food, and the depression trials behind its approval gave it with meals.

The label also calls for a gradual start: 10 mg daily for 7 days, then 20 mg, with an optional increase to 40 mg after at least another 7 days. When stopping, the label recommends tapering rather than stopping suddenly. Our guide to Viibryd dosage walks through the schedule.

Who Might Consider Viibryd for Anxiety?

Viibryd usually isn’t the first medication tried for anxiety. A prescriber might consider it in situations like these:

• You have both depression and anxiety, since depression is its approved use.
• You’ve tried first-line anxiety medications without enough benefit or with side effects you couldn’t tolerate.
• You can reliably take a daily dose with food.

It may be a poorer fit if you have a sensitive stomach or irritable bowel symptoms. The label also calls for screening for bipolar disorder before starting, prohibits combining it with MAO inhibitors, and limits the dose when it’s taken with certain drugs that affect liver enzymes. Our guide to choosing an anxiety medication compares other options.

How Siggy Fits In

Siggy’s licensed prescribers treat anxiety and depression, and they choose medication after reviewing your full anonymous intake. Whether Viibryd makes sense, especially off-label for anxiety, depends on your history, past medications, and which side effects matter most to you.

The intake needs no name, email, or account, so you can share what you’ve tried, what helped, and what didn’t, in your own words. A licensed prescriber reviews everything before anything is prescribed. Once you’re in care, if stomach upset or other side effects show up in the first weeks, you can raise them with your care team so a prescriber can review whether to adjust your dose or plan, so you’re not on your own until the next appointment.

Siggy isn’t an emergency service. This article is for education only and isn’t a substitute for personal medical advice. It reflects sources available as of October 2026.

Start Your Anonymous Intake

Viibryd has real but modest evidence for anxiety, and it’s one option among several. If anxiety is wearing you down and you want a prescriber to weigh your options with you, start your anonymous intake. It’s free, no name or email is required, and a licensed prescriber reviews everything before anything is prescribed.